Boston Scientific (BSX) Other Accumulated Expenses (2009 - 2026)

Boston Scientific (BSX) has 18 years of Other Accumulated Expenses data on file, last reported at $875.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 5.2% year-over-year to $875.0 million; the trailing twelve-month figure through Mar 2026 stood at $875.0 million (down 5.2% YoY), and the FY2025 full-year result was $795.0 million, down 10.37% from the prior year.
• Other Accumulated Expenses advanced to $875.0 million in Q1 2026, from $795.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.0 billion in Q1 2022 to a low of $752.0 million in Q3 2022.
• A 5-year average of $855.1 million and a median of $862.0 million in 2025 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses soared 46.67% in 2022 and declined 23.89% in 2023, its largest moves.
• Tracing BSX's Other Accumulated Expenses over 5 years: stood at $761.0 million in 2022, then rose by 6.96% to $814.0 million in 2023, then gained by 8.97% to $887.0 million in 2024, then fell by 10.37% to $795.0 million in 2025, then gained by 10.06% to $875.0 million in 2026.
• Business Quant data shows BSX's Other Accumulated Expenses at $875.0 million in Q1 2026, $795.0 million in Q4 2025, and $862.0 million in Q3 2025.